Psychiatry today is a barren tundra, writes medical historian Edward Shorter, where drugs that don't work are used to treat diseases that don't exist. In this provocative volume, Shorter illuminates this dismal landscape, in a revealing account of why psychiatry is "losing ground" in the struggle to treat depression.
Naturally, the book looks at such culprits as the pharmaceutical industry, which is not inclined to market drugs once the patent expires, leading to the endless introduction of new--but not necessarily better--drugs. But the heart of the book focuses on an unexpected villain: the FDA, the very agency charged with ensuring drug safety and effectiveness. Shorter describes how the FDA permits companies to test new products only against placebo. If you can beat sugar pills, you get your drug licensed, whether or not it is actually better than (or even as good as) current medications, thus sweeping from the shelves drugs that may be superior but have lost patent protection. The book also examines the FDA's early power struggles against the drug industry, an influence-grab that had little to do with science, and which left barbiturates, opiates, and amphetamines all underprescribed, despite the fact that under careful supervision they are better at treating depression, with fewer side effects, than the newer drugs in the Prozac family. Shorter also castigates academia, showing how two forms of depression, melancholia and nonmelancholia--"as different from each other as chalk and cheese"--became squeezed into one dubious classification, major depression, which was essentially a political artifact born of academic infighting.
An astonishing and troubling look at modern psychiatry, Losing Ground is a book that is sure to spark controversy for years to come.
"synopsis" may belong to another edition of this title.
Edward Shorter is Hannah Chair in the History of Medicine and Professor of Psychiatry at the University of Toronto.
"Excellent...informative and intriguing..."--New England Journal of Medicine
"About this title" may belong to another edition of this title.
Shipping:
FREE
Within U.S.A.
Shipping:
US$ 2.64
Within U.S.A.
Seller: Better World Books, Mishawaka, IN, U.S.A.
Condition: Good. 1st Edition. Former library book; may include library markings. Used book that is in clean, average condition without any missing pages. Seller Inventory # 325157-6
Quantity: 2 available
Seller: Unique Books, Lexington, KY, U.S.A.
Hardcover. Condition: Fine. Dust Jacket Condition: Fine. 1st Edition. Seller Inventory # b-926-24-jn
Quantity: 1 available
Seller: Books Unplugged, Amherst, NY, U.S.A.
Condition: USED_GOOD. Buy with confidence! Book is in good condition with minor wear to the pages, binding, and minor marks within 1.45. Seller Inventory # bk0195368746xvz189zvxgdd
Quantity: 1 available
Seller: Better World Books Ltd, Dunfermline, United Kingdom
Condition: Very Good. 1st Edition. Ships from the UK. Used book that is in excellent condition. May show signs of wear or have minor defects. Seller Inventory # 13692539-6
Quantity: 1 available
Seller: 369 Bookstore _[~ 369 Pyramid Inc ~]_, Dover, DE, U.S.A.
Hardcover. Condition: Good. Psychiatry today is a barren tundra, writes medical historian Edward Shorter, where drugs that don\'t work are used to treat diseases that don\'t exist. In this provocative volume, Shorter illuminates this dismal landscape, in a revealing account of why psychiatry is \"losing ground\" in the struggle to treat depression.Naturally, the book looks at such culprits as the pharmaceutical industry, which is not inclined to market drugs once the patent expires, leading to the endless introduction of new--but not necessarily better--drugs. But the heart of the book focuses on an unexpected villain: the FDA, the very agency charged with ensuring drug safety and effectiveness. Shorter describes how the FDA permits companies to test new products only against placebo. If you can beat sugar pills, you get your drug licensed, whether or not it is actually better than (or even as good as) current medications, thus sweeping from the shelves drugs that may be superior but have lost patent protection. The book also examines the FDA\'s early power struggles against the drug industry, an influence-grab that had little to do with science, and which left barbiturates, opiates, and amphetamines all underprescribed, despite the fact that under careful supervision they are better at treating depression, with fewer side effects, than the newer drugs in the Prozac family. Shorter also castigates academia, showing how two forms of depression, melancholia and nonmelancholia--\"as different from each other as chalk and cheese\"--became squeezed into one dubious classification, major depression, which was essentially a political artifact born of academic infighting.An astonishing and troubling look at modern psychiatry, Losing Ground is a book that is sure to spark controversy for years to come. Seller Inventory # AMPLE0195368746
Quantity: 1 available
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New. Seller Inventory # 5587174-n
Quantity: 5 available
Seller: Campbell Bookstore, Austin, TX, U.S.A.
Condition: NEW. Seller Inventory # NewCamp0195368746
Quantity: 1 available
Seller: GoldenWavesOfBooks, Fayetteville, TX, U.S.A.
Hardcover. Condition: NEW. New. Fast Shipping and good customer service. Seller Inventory # Holz_New_0195368746
Quantity: 1 available
Seller: Wizard Books, Long Beach, CA, U.S.A.
Hardcover. Condition: NEW. New. Seller Inventory # Wizard0195368746
Quantity: 1 available
Seller: Front Cover Books, Denver, CO, U.S.A.
Condition: NEW. Seller Inventory # FrontCover0195368746
Quantity: 1 available